Market Insights Health OTC Pharmaceuticals

Sleep Aids - United States

United States

In 2024, the revenue in the Sleep Aids market market in the United States is projected to reach a significant amount of €1.95bn.
This market is expected to experience a steady annual growth rate of 3.80% (CAGR 2024-2029).
When compared to other countries around Worldwide, the in the United States stands out as the leading revenue generator, with a substantial amount of €1.95bn in 2024.
Moreover, considering the total population figures, the per person revenue the in the United States is estimated to be €5.71 in 2024.
The United States is experiencing a trend in the Sleep Aids market, with a growing demand for natural and non-habit forming products.

Key regions: Europe, Germany, Canada, United Kingdom, United States

Marché

Région

Comparaison de régions

Monnaie

Analyst Opinion

The Sleep Aids market in the United States is experiencing significant growth due to a combination of customer preferences, market trends, local special circumstances, and underlying macroeconomic factors.

Customer preferences: Customers in the United States are increasingly seeking sleep aids to help them achieve a better night's sleep. Factors such as high levels of stress, busy lifestyles, and the prevalence of technology use before bed have contributed to an increased demand for sleep aids. Additionally, the aging population in the United States is also driving the demand for sleep aids, as older individuals often experience more sleep disturbances and seek solutions to improve their sleep quality.

Trends in the market: One of the key trends in the Sleep Aids market in the United States is the growing popularity of natural and herbal sleep aids. Customers are becoming more conscious of the ingredients in the products they use and are seeking natural alternatives to traditional sleep aids. This trend is reflected in the increasing number of natural sleep aid products available in the market, including herbal supplements and aromatherapy products.Another trend in the market is the rise of wearable sleep technology. Customers are increasingly using wearable devices, such as smartwatches and sleep trackers, to monitor their sleep patterns and identify areas for improvement. This trend is driving the demand for sleep aids that complement wearable technology, such as sleep-promoting apps and devices that integrate with these wearables.

Local special circumstances: The United States has a highly developed healthcare system, which includes specialized sleep clinics and a wide range of healthcare professionals who can diagnose and treat sleep disorders. This infrastructure has contributed to a greater awareness of sleep disorders and the importance of sleep health among the general population. As a result, more individuals are seeking sleep aids to address their sleep issues, leading to the growth of the Sleep Aids market in the United States.

Underlying macroeconomic factors: The United States has a strong economy, which has contributed to increased consumer spending power. As a result, individuals are more willing to invest in sleep aids to improve their sleep quality and overall well-being. Additionally, the United States has a high level of healthcare expenditure, which allows for greater accessibility and affordability of sleep aids.In conclusion, the Sleep Aids market in the United States is experiencing growth due to customer preferences for better sleep, trends such as the popularity of natural sleep aids and wearable sleep technology, local special circumstances such as a well-developed healthcare system, and underlying macroeconomic factors such as a strong economy and high healthcare expenditure. This growth is expected to continue as individuals prioritize their sleep health and seek solutions to improve their sleep quality.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.